Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored

Background. Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Ministry of Health mandate to implement such a switch. Methods. Forty-one stable Prograf (Astellas) re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Transplant
Autors principals: González, Fernando, López, René, Arriagada, Elizabeth, Carrasco, René, Gallardo, Natalia, Lorca, Eduardo
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5299171/
https://ncbi.nlm.nih.gov/pubmed/28246556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5646858
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars